(Q36673006)

15 August 2017

1 reference

title

Pregabalin for the treatment of painful neuropathy (English)

1 reference

15 August 2017

Travis E Sonnett

1

1 reference

PubMed ID

17144773

15 August 2017

Stephen M Setter

series ordinal

2

1 reference

PubMed ID

17144773

15 August 2017

R Keith Campbell

series ordinal

3

1 reference

15 August 2017

1 November 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

11

1 reference

15 August 2017

1629-1635

1 reference

Potential mechanisms of neuropathic pain in diabetes

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

The management of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Clinical characteristics and economic costs of patients with painful neuropathic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Acute cellular alterations in the hippocampus after status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Pregabalin pharmacology and its relevance to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer's disease. Lu25-109 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.11.1629

10.1586/14737175.6.11.1629

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17144773